Adalat and Lip erosion - a phase IV clinical study of FDA data

Summary:

Lip erosion is reported as a side effect among people who take Adalat (nifedipine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Diabetes.

The phase IV clinical study analyzes which people have Lip erosion when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Lip erosion?

Lip erosion (peeling off of lip) is found to be associated with 156 drugs and 395 conditions by eHealthMe. Check the latest studies of Lip erosion.

On Jul, 10, 2026

20,643 people reported to have side effects when taking Adalat.
Among them, 24 people (0.12%) have Lip erosion.

Among these 24 people:

How long have people been on Adalat when they have Lip erosion? *

What is the gender of people who have Lip erosion when taking Adalat? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Lip erosion when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides Lip erosion? *

Fever: 17 people, 70.83%
Erythema Multiforme (a type of hypersensitivity reaction): 16 people, 66.67%
Rashes (redness): 16 people, 66.67%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 15 people, 62.50%
Itching: 12 people, 50.00%
White Blood Cell Count Increased: 6 people, 25.00%
Oral Mucosa Erosion (erosion of mouth mucous membrane): 5 people, 20.83%
Constipation: 4 people, 16.67%
Lip Exfoliation: 4 people, 16.67%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 16.67%

What are the existing conditions these people have? *

Diabetes: 15 people, 62.50%
Pain: 12 people, 50.00%
Sleep Disorder: 11 people, 45.83%
Heart Disease: 11 people, 45.83%
Anaesthesia: 11 people, 45.83%
Agitation (state of anxiety or nervous excitement): 11 people, 45.83%
Electrolyte Imbalance: 8 people, 33.33%
Constipation: 8 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 16.67%
Insomnia (sleeplessness): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have Lip erosion?

- Check whether Lip erosion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

Lip erosion treatments and more:

Lip erosion (993 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lip erosion:

Lip erosion (156 drugs)

Browse all the conditions that are associated with Lip erosion:

Lip erosion (395 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.